Lobbying Activity Report

1334-14058

Designated Filer name: Bradley Lavigne
Client: Emergent BioSolutions Canada Inc. (formerly Adapt Pharma Canada Ltd.)
Associated registration: 1688-1334-7
Lobbying Activity date: 2021-10-26
Arranged a meeting: Yes
Posted date: 2021-11-15

Senior Public Office Holders who were lobbied in this activity: George Smith, Communications Director
Office of the Premier
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
To increase access to publicly funded NARCAN®(Naloxone HCI) Nasal Spray.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
Date Modified: